| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chagas Disease | 24 | 2026 | 319 | 6.280 |
Why?
|
| Trypanosoma cruzi | 18 | 2026 | 255 | 5.710 |
Why?
|
| Pregnancy | 217 | 2026 | 7390 | 5.060 |
Why?
|
| Pregnancy Complications, Infectious | 19 | 2025 | 502 | 4.550 |
Why?
|
| Pregnancy Outcome | 46 | 2021 | 614 | 4.530 |
Why?
|
| Prenatal Care | 51 | 2022 | 343 | 3.720 |
Why?
|
| Immunogenicity, Vaccine | 4 | 2025 | 124 | 3.260 |
Why?
|
| Cyclonic Storms | 13 | 2020 | 82 | 2.930 |
Why?
|
| Premature Birth | 27 | 2023 | 418 | 2.830 |
Why?
|
| Pregnancy Complications | 24 | 2017 | 542 | 2.760 |
Why?
|
| Infectious Disease Transmission, Vertical | 13 | 2025 | 259 | 2.710 |
Why?
|
| Disasters | 12 | 2017 | 101 | 2.660 |
Why?
|
| Developing Countries | 32 | 2023 | 303 | 2.530 |
Why?
|
| Viral Vaccines | 4 | 2025 | 321 | 2.350 |
Why?
|
| Infant, Low Birth Weight | 30 | 2023 | 169 | 2.260 |
Why?
|
| Birth Weight | 30 | 2024 | 345 | 2.120 |
Why?
|
| Female | 236 | 2026 | 70240 | 2.040 |
Why?
|
| Lassa Fever | 3 | 2025 | 14 | 2.040 |
Why?
|
| Maternal Health Services | 13 | 2013 | 46 | 1.980 |
Why?
|
| Pregnancy Complications, Parasitic | 8 | 2024 | 25 | 1.970 |
Why?
|
| Infant Mortality | 35 | 2020 | 181 | 1.950 |
Why?
|
| Infant, Newborn | 100 | 2024 | 8546 | 1.880 |
Why?
|
| Lassa virus | 2 | 2025 | 25 | 1.820 |
Why?
|
| Diabetes, Gestational | 6 | 2017 | 111 | 1.790 |
Why?
|
| Chikungunya Fever | 4 | 2025 | 36 | 1.700 |
Why?
|
| Zika Virus Infection | 7 | 2023 | 171 | 1.650 |
Why?
|
| Delivery, Obstetric | 21 | 2020 | 256 | 1.610 |
Why?
|
| Humans | 269 | 2026 | 130075 | 1.600 |
Why?
|
| Public Health | 8 | 2020 | 269 | 1.560 |
Why?
|
| Louisiana | 19 | 2022 | 137 | 1.440 |
Why?
|
| Periodontal Diseases | 8 | 2015 | 31 | 1.410 |
Why?
|
| Antibodies, Protozoan | 7 | 2026 | 102 | 1.390 |
Why?
|
| Stress Disorders, Post-Traumatic | 11 | 2015 | 639 | 1.330 |
Why?
|
| Vaccines | 4 | 2023 | 386 | 1.310 |
Why?
|
| Petroleum Pollution | 3 | 2021 | 4 | 1.230 |
Why?
|
| Syphilis | 5 | 2022 | 95 | 1.220 |
Why?
|
| Obstetric Labor, Premature | 15 | 2016 | 76 | 1.190 |
Why?
|
| Global Health | 13 | 2018 | 622 | 1.170 |
Why?
|
| Adult | 106 | 2026 | 31012 | 1.160 |
Why?
|
| Mental Health | 7 | 2014 | 374 | 1.150 |
Why?
|
| Cesarean Section | 14 | 2020 | 421 | 1.110 |
Why?
|
| Meta-Analysis as Topic | 7 | 2025 | 169 | 1.090 |
Why?
|
| Chikungunya virus | 2 | 2025 | 31 | 1.090 |
Why?
|
| Argentina | 26 | 2026 | 54 | 1.080 |
Why?
|
| Maternal Mortality | 19 | 2014 | 78 | 1.070 |
Why?
|
| Stress, Psychological | 6 | 2019 | 532 | 1.030 |
Why?
|
| Mothers | 9 | 2019 | 376 | 1.000 |
Why?
|
| Sex Workers | 1 | 2026 | 6 | 0.970 |
Why?
|
| Postpartum Hemorrhage | 10 | 2013 | 110 | 0.960 |
Why?
|
| Gestational Age | 26 | 2021 | 1210 | 0.940 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2026 | 46 | 0.940 |
Why?
|
| Mexico | 12 | 2024 | 190 | 0.930 |
Why?
|
| Zika Virus | 4 | 2023 | 148 | 0.930 |
Why?
|
| Smallpox Vaccine | 1 | 2026 | 40 | 0.930 |
Why?
|
| Nitroimidazoles | 3 | 2020 | 49 | 0.920 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 337 | 0.910 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 348 | 0.900 |
Why?
|
| Birth Rate | 3 | 2020 | 15 | 0.900 |
Why?
|
| Perinatal Mortality | 8 | 2013 | 44 | 0.860 |
Why?
|
| Young Adult | 46 | 2026 | 9979 | 0.860 |
Why?
|
| Dengue | 4 | 2014 | 125 | 0.860 |
Why?
|
| Medication Adherence | 2 | 2026 | 336 | 0.850 |
Why?
|
| Socioeconomic Factors | 17 | 2019 | 903 | 0.840 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2023 | 231 | 0.830 |
Why?
|
| Parturition | 4 | 2024 | 66 | 0.830 |
Why?
|
| Depression, Postpartum | 5 | 2010 | 52 | 0.810 |
Why?
|
| Maternal Welfare | 6 | 2012 | 13 | 0.800 |
Why?
|
| Trypanosoma | 1 | 2023 | 8 | 0.790 |
Why?
|
| Microcephaly | 4 | 2021 | 347 | 0.770 |
Why?
|
| Drug Monitoring | 1 | 2026 | 289 | 0.770 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2024 | 70 | 0.770 |
Why?
|
| Prospective Studies | 30 | 2026 | 6401 | 0.760 |
Why?
|
| HIV Infections | 4 | 2026 | 2043 | 0.760 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2026 | 784 | 0.760 |
Why?
|
| Anti-HIV Agents | 1 | 2026 | 345 | 0.750 |
Why?
|
| Belgium | 30 | 2020 | 43 | 0.750 |
Why?
|
| Environmental Exposure | 3 | 2017 | 292 | 0.730 |
Why?
|
| Periodontitis | 5 | 2013 | 19 | 0.730 |
Why?
|
| Parity | 11 | 2019 | 77 | 0.720 |
Why?
|
| Maternal Exposure | 3 | 2022 | 148 | 0.700 |
Why?
|
| Risk Factors | 42 | 2020 | 10959 | 0.700 |
Why?
|
| Women's Health | 5 | 2019 | 133 | 0.690 |
Why?
|
| Craniosynostoses | 1 | 2023 | 146 | 0.690 |
Why?
|
| Midwifery | 9 | 2019 | 41 | 0.680 |
Why?
|
| Stillbirth | 11 | 2016 | 96 | 0.680 |
Why?
|
| Perinatal Care | 5 | 2019 | 65 | 0.670 |
Why?
|
| Infant, Small for Gestational Age | 3 | 2019 | 62 | 0.660 |
Why?
|
| Population Surveillance | 8 | 2020 | 393 | 0.660 |
Why?
|
| Adolescent | 50 | 2025 | 20796 | 0.650 |
Why?
|
| Maternal Age | 9 | 2016 | 134 | 0.650 |
Why?
|
| Home Childbirth | 6 | 2013 | 39 | 0.620 |
Why?
|
| Logistic Models | 15 | 2019 | 1794 | 0.610 |
Why?
|
| Abortion, Spontaneous | 5 | 2017 | 81 | 0.600 |
Why?
|
| Evidence-Based Medicine | 9 | 2016 | 641 | 0.590 |
Why?
|
| Metals | 1 | 2019 | 70 | 0.580 |
Why?
|
| Vaccination | 7 | 2024 | 1052 | 0.580 |
Why?
|
| Fetal Blood | 7 | 2022 | 179 | 0.570 |
Why?
|
| Biomedical Research | 3 | 2020 | 558 | 0.560 |
Why?
|
| Infant | 29 | 2023 | 13265 | 0.550 |
Why?
|
| Syphilis, Congenital | 4 | 2022 | 32 | 0.550 |
Why?
|
| Honduras | 6 | 2024 | 25 | 0.550 |
Why?
|
| Zambia | 9 | 2023 | 21 | 0.550 |
Why?
|
| Protozoan Vaccines | 1 | 2019 | 101 | 0.540 |
Why?
|
| Oxytocin | 5 | 2011 | 68 | 0.540 |
Why?
|
| Public Health Administration | 1 | 2017 | 9 | 0.530 |
Why?
|
| Oxytocics | 4 | 2010 | 25 | 0.530 |
Why?
|
| Review Literature as Topic | 2 | 2008 | 55 | 0.520 |
Why?
|
| Prevalence | 13 | 2026 | 2687 | 0.520 |
Why?
|
| Nausea | 1 | 2017 | 83 | 0.510 |
Why?
|
| Depression | 5 | 2012 | 1313 | 0.510 |
Why?
|
| Fertilization in Vitro | 2 | 2017 | 152 | 0.510 |
Why?
|
| Disease Transmission, Infectious | 1 | 2017 | 71 | 0.510 |
Why?
|
| Health Status | 3 | 2012 | 371 | 0.510 |
Why?
|
| Uruguay | 13 | 2023 | 14 | 0.510 |
Why?
|
| Risk Assessment | 8 | 2020 | 3677 | 0.500 |
Why?
|
| Glucocorticoids | 5 | 2016 | 345 | 0.490 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2015 | 129 | 0.490 |
Why?
|
| Infertility | 1 | 2017 | 75 | 0.490 |
Why?
|
| Vomiting | 1 | 2017 | 103 | 0.490 |
Why?
|
| Smoking Cessation | 6 | 2016 | 189 | 0.490 |
Why?
|
| Obstetrics | 8 | 2013 | 237 | 0.480 |
Why?
|
| Surveys and Questionnaires | 15 | 2017 | 4035 | 0.470 |
Why?
|
| Birth Certificates | 5 | 2013 | 14 | 0.470 |
Why?
|
| Health Services Accessibility | 10 | 2020 | 698 | 0.470 |
Why?
|
| Validation Studies as Topic | 1 | 2015 | 12 | 0.460 |
Why?
|
| Serologic Tests | 3 | 2021 | 123 | 0.460 |
Why?
|
| Apgar Score | 4 | 2020 | 48 | 0.450 |
Why?
|
| Maternal Health | 3 | 2021 | 29 | 0.440 |
Why?
|
| Cross-Sectional Studies | 11 | 2026 | 3782 | 0.440 |
Why?
|
| Poverty | 3 | 2014 | 461 | 0.440 |
Why?
|
| Perception | 2 | 2015 | 228 | 0.430 |
Why?
|
| Pandemics | 4 | 2024 | 1112 | 0.430 |
Why?
|
| Tropical Medicine | 2 | 2014 | 103 | 0.430 |
Why?
|
| Democratic Republic of the Congo | 8 | 2026 | 15 | 0.430 |
Why?
|
| Indians, South American | 1 | 2014 | 10 | 0.420 |
Why?
|
| Child | 17 | 2026 | 26168 | 0.420 |
Why?
|
| Emigration and Immigration | 6 | 2010 | 80 | 0.420 |
Why?
|
| Encephalitis, St. Louis | 1 | 2014 | 24 | 0.420 |
Why?
|
| Adaptation, Psychological | 3 | 2015 | 426 | 0.410 |
Why?
|
| Cohort Studies | 14 | 2023 | 5034 | 0.410 |
Why?
|
| Sleep Wake Disorders | 1 | 2017 | 199 | 0.410 |
Why?
|
| Labor Stage, Third | 6 | 2011 | 6 | 0.410 |
Why?
|
| Acculturation | 5 | 2016 | 63 | 0.400 |
Why?
|
| Mexican Americans | 4 | 2017 | 162 | 0.400 |
Why?
|
| Research Design | 7 | 2025 | 711 | 0.400 |
Why?
|
| Emigrants and Immigrants | 2 | 2012 | 169 | 0.390 |
Why?
|
| Universities | 2 | 2017 | 125 | 0.390 |
Why?
|
| Health Knowledge, Attitudes, Practice | 8 | 2021 | 907 | 0.380 |
Why?
|
| Postpartum Period | 4 | 2020 | 238 | 0.380 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2016 | 331 | 0.380 |
Why?
|
| Obstetric Labor Complications | 6 | 2019 | 93 | 0.380 |
Why?
|
| Reproduction | 1 | 2014 | 210 | 0.370 |
Why?
|
| Periodontal Pocket | 4 | 2013 | 5 | 0.370 |
Why?
|
| Periodontal Index | 4 | 2013 | 5 | 0.370 |
Why?
|
| Periodontal Attachment Loss | 4 | 2013 | 6 | 0.370 |
Why?
|
| United States | 28 | 2022 | 11893 | 0.370 |
Why?
|
| Disaster Planning | 3 | 2009 | 68 | 0.370 |
Why?
|
| Glucose Intolerance | 1 | 2012 | 80 | 0.360 |
Why?
|
| Social Class | 7 | 2017 | 213 | 0.360 |
Why?
|
| Schools, Public Health | 1 | 2011 | 5 | 0.350 |
Why?
|
| Safety Management | 2 | 2012 | 111 | 0.350 |
Why?
|
| Delivery of Health Care | 5 | 2024 | 683 | 0.350 |
Why?
|
| Obesity | 2 | 2013 | 2398 | 0.350 |
Why?
|
| Education, Graduate | 1 | 2011 | 20 | 0.350 |
Why?
|
| Internationality | 2 | 2016 | 128 | 0.350 |
Why?
|
| Schools, Medical | 1 | 2012 | 113 | 0.350 |
Why?
|
| Health Services Needs and Demand | 4 | 2020 | 179 | 0.340 |
Why?
|
| Trypanocidal Agents | 3 | 2025 | 33 | 0.340 |
Why?
|
| Patient Care Planning | 1 | 2012 | 124 | 0.340 |
Why?
|
| Infant, Premature | 10 | 2018 | 861 | 0.340 |
Why?
|
| Educational Status | 8 | 2016 | 276 | 0.340 |
Why?
|
| Emblems and Insignia | 1 | 2011 | 1 | 0.340 |
Why?
|
| Twins | 6 | 2002 | 70 | 0.340 |
Why?
|
| Fetal Development | 2 | 2024 | 121 | 0.330 |
Why?
|
| Competency-Based Education | 1 | 2011 | 84 | 0.320 |
Why?
|
| Perinatal Death | 3 | 2016 | 29 | 0.320 |
Why?
|
| Battered Women | 1 | 2010 | 7 | 0.320 |
Why?
|
| Infant Health | 2 | 2021 | 17 | 0.320 |
Why?
|
| Mississippi | 3 | 2020 | 35 | 0.320 |
Why?
|
| Pre-Eclampsia | 5 | 2010 | 226 | 0.320 |
Why?
|
| Spouse Abuse | 1 | 2010 | 15 | 0.320 |
Why?
|
| Endemic Diseases | 3 | 2026 | 60 | 0.320 |
Why?
|
| Odds Ratio | 11 | 2015 | 1210 | 0.310 |
Why?
|
| Misoprostol | 1 | 2010 | 23 | 0.310 |
Why?
|
| Child Health Services | 1 | 2011 | 86 | 0.310 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2013 | 350 | 0.310 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 4 | 2007 | 16 | 0.300 |
Why?
|
| Puerperal Infection | 3 | 2015 | 7 | 0.300 |
Why?
|
| Periodicals as Topic | 1 | 2012 | 181 | 0.300 |
Why?
|
| Clinical Laboratory Techniques | 4 | 2020 | 141 | 0.300 |
Why?
|
| Income | 4 | 2022 | 137 | 0.300 |
Why?
|
| Body Mass Index | 5 | 2013 | 1694 | 0.290 |
Why?
|
| Health Personnel | 5 | 2021 | 538 | 0.290 |
Why?
|
| Seroepidemiologic Studies | 4 | 2026 | 158 | 0.290 |
Why?
|
| Crime Victims | 1 | 2010 | 76 | 0.290 |
Why?
|
| Hypertension | 2 | 2017 | 1352 | 0.290 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2016 | 93 | 0.280 |
Why?
|
| Smoking | 6 | 2016 | 928 | 0.280 |
Why?
|
| Relief Work | 1 | 2008 | 29 | 0.280 |
Why?
|
| Interpersonal Relations | 1 | 2010 | 221 | 0.280 |
Why?
|
| Diabetes Mellitus | 3 | 2012 | 888 | 0.270 |
Why?
|
| Episiotomy | 5 | 2009 | 17 | 0.270 |
Why?
|
| Social Support | 6 | 2012 | 369 | 0.270 |
Why?
|
| Latin America | 9 | 2020 | 108 | 0.270 |
Why?
|
| Contraceptives, Oral | 5 | 1991 | 37 | 0.270 |
Why?
|
| Registries | 13 | 2018 | 1607 | 0.260 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2020 | 1262 | 0.260 |
Why?
|
| Health Status Disparities | 1 | 2010 | 278 | 0.250 |
Why?
|
| Mass Screening | 6 | 2021 | 817 | 0.250 |
Why?
|
| Case-Control Studies | 7 | 2016 | 3349 | 0.250 |
Why?
|
| Clinical Competence | 2 | 2011 | 1042 | 0.250 |
Why?
|
| Self Report | 4 | 2021 | 552 | 0.250 |
Why?
|
| Counseling | 4 | 2015 | 236 | 0.240 |
Why?
|
| Pregnancy, Multiple | 5 | 2017 | 44 | 0.230 |
Why?
|
| Africa South of the Sahara | 5 | 2018 | 120 | 0.230 |
Why?
|
| Sensitivity and Specificity | 5 | 2020 | 2076 | 0.230 |
Why?
|
| Breech Presentation | 3 | 2020 | 18 | 0.230 |
Why?
|
| Gynecology | 2 | 1998 | 126 | 0.230 |
Why?
|
| New Orleans | 3 | 2015 | 13 | 0.230 |
Why?
|
| Anxiety | 3 | 2016 | 1004 | 0.220 |
Why?
|
| Prenatal Diagnosis | 7 | 2021 | 611 | 0.220 |
Why?
|
| Host-Parasite Interactions | 1 | 2025 | 71 | 0.220 |
Why?
|
| Child Welfare | 1 | 2005 | 70 | 0.210 |
Why?
|
| Middle Aged | 15 | 2017 | 28315 | 0.210 |
Why?
|
| Menstrual Cycle | 1 | 2004 | 33 | 0.210 |
Why?
|
| Quality Improvement | 3 | 2019 | 708 | 0.210 |
Why?
|
| Weight Gain | 1 | 2006 | 385 | 0.200 |
Why?
|
| Text Messaging | 2 | 2015 | 41 | 0.200 |
Why?
|
| Follow-Up Studies | 6 | 2020 | 5166 | 0.200 |
Why?
|
| West Nile Fever | 2 | 2016 | 145 | 0.200 |
Why?
|
| Rwanda | 1 | 2023 | 8 | 0.200 |
Why?
|
| C-Peptide | 1 | 2003 | 105 | 0.190 |
Why?
|
| Morbidity | 2 | 2022 | 257 | 0.190 |
Why?
|
| Aluminum | 1 | 2023 | 14 | 0.190 |
Why?
|
| Decision Making | 3 | 2017 | 712 | 0.190 |
Why?
|
| Antibodies, Neutralizing | 2 | 2025 | 523 | 0.190 |
Why?
|
| Coinfection | 1 | 2025 | 186 | 0.190 |
Why?
|
| Data Accuracy | 1 | 2023 | 28 | 0.190 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2008 | 774 | 0.190 |
Why?
|
| Fetal Growth Retardation | 2 | 2024 | 252 | 0.190 |
Why?
|
| Uganda | 1 | 2023 | 83 | 0.190 |
Why?
|
| Mental Disorders | 1 | 2010 | 901 | 0.190 |
Why?
|
| Delivery Rooms | 2 | 2013 | 21 | 0.190 |
Why?
|
| Awareness | 2 | 2021 | 78 | 0.180 |
Why?
|
| Pediatrics | 1 | 2012 | 1242 | 0.180 |
Why?
|
| Male | 23 | 2024 | 64382 | 0.180 |
Why?
|
| Quality of Health Care | 6 | 2010 | 407 | 0.180 |
Why?
|
| Incidence | 7 | 2021 | 3321 | 0.180 |
Why?
|
| Comorbidity | 4 | 2020 | 1584 | 0.180 |
Why?
|
| Neonatology | 3 | 2013 | 64 | 0.180 |
Why?
|
| Multivariate Analysis | 5 | 2016 | 1374 | 0.180 |
Why?
|
| Health Promotion | 2 | 2010 | 416 | 0.180 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 323 | 0.180 |
Why?
|
| Trichomonas vaginalis | 1 | 2021 | 10 | 0.170 |
Why?
|
| Trichomonas Vaginitis | 1 | 2021 | 14 | 0.170 |
Why?
|
| History, 21st Century | 2 | 2012 | 259 | 0.170 |
Why?
|
| Antibodies, Viral | 3 | 2025 | 1171 | 0.170 |
Why?
|
| Retrospective Studies | 13 | 2020 | 17538 | 0.170 |
Why?
|
| Asymptomatic Diseases | 1 | 2021 | 77 | 0.170 |
Why?
|
| Europe | 6 | 2003 | 363 | 0.170 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2021 | 27 | 0.170 |
Why?
|
| Extraction, Obstetrical | 1 | 2001 | 9 | 0.170 |
Why?
|
| Adjuvants, Immunologic | 1 | 2023 | 391 | 0.170 |
Why?
|
| Child Development | 1 | 2023 | 267 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2016 | 509 | 0.170 |
Why?
|
| Observation | 1 | 2001 | 40 | 0.170 |
Why?
|
| Treponema pallidum | 1 | 2021 | 48 | 0.170 |
Why?
|
| Guideline Adherence | 5 | 2013 | 387 | 0.170 |
Why?
|
| Hospitals | 3 | 2013 | 430 | 0.170 |
Why?
|
| History, 20th Century | 2 | 2012 | 361 | 0.160 |
Why?
|
| Alabama | 1 | 2020 | 44 | 0.160 |
Why?
|
| Parasite Load | 1 | 2020 | 31 | 0.160 |
Why?
|
| Health Information Systems | 1 | 2021 | 34 | 0.160 |
Why?
|
| Motivation | 3 | 2015 | 328 | 0.160 |
Why?
|
| Professional-Patient Relations | 2 | 2015 | 92 | 0.160 |
Why?
|
| Dimensional Measurement Accuracy | 1 | 2019 | 6 | 0.160 |
Why?
|
| Maternal-Child Health Services | 1 | 2019 | 13 | 0.150 |
Why?
|
| Quality Assurance, Health Care | 4 | 2019 | 205 | 0.150 |
Why?
|
| Fetus | 2 | 2023 | 567 | 0.150 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2021 | 192 | 0.150 |
Why?
|
| Cephalometry | 1 | 2019 | 47 | 0.150 |
Why?
|
| Cadmium | 1 | 2019 | 33 | 0.150 |
Why?
|
| Mercury | 1 | 2019 | 31 | 0.150 |
Why?
|
| Pregnancy Rate | 2 | 2017 | 39 | 0.150 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 3026 | 0.150 |
Why?
|
| Cerebral Palsy | 1 | 2001 | 86 | 0.150 |
Why?
|
| Placenta | 1 | 2003 | 495 | 0.150 |
Why?
|
| Bias | 6 | 2006 | 148 | 0.150 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 250 | 0.150 |
Why?
|
| Dried Blood Spot Testing | 1 | 2019 | 27 | 0.150 |
Why?
|
| Stress, Physiological | 1 | 2001 | 256 | 0.150 |
Why?
|
| Regression Analysis | 4 | 2010 | 759 | 0.150 |
Why?
|
| North Carolina | 5 | 2006 | 40 | 0.140 |
Why?
|
| Africa | 7 | 2016 | 135 | 0.140 |
Why?
|
| World Health Organization | 2 | 2018 | 116 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 6 | 2016 | 1282 | 0.140 |
Why?
|
| Diagnosis | 2 | 2016 | 29 | 0.140 |
Why?
|
| Pregnancy Trimester, First | 4 | 2013 | 115 | 0.140 |
Why?
|
| Viral Plaque Assay | 1 | 2018 | 43 | 0.140 |
Why?
|
| Labor, Obstetric | 3 | 1995 | 93 | 0.140 |
Why?
|
| Infant, Premature, Diseases | 2 | 2011 | 252 | 0.140 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 525 | 0.140 |
Why?
|
| Residence Characteristics | 5 | 2010 | 293 | 0.140 |
Why?
|
| Disease Outbreaks | 2 | 2024 | 311 | 0.140 |
Why?
|
| Marital Status | 3 | 2009 | 33 | 0.140 |
Why?
|
| Databases, Factual | 1 | 2023 | 1227 | 0.130 |
Why?
|
| Neutralization Tests | 1 | 2018 | 226 | 0.130 |
Why?
|
| Mentors | 1 | 2019 | 169 | 0.130 |
Why?
|
| Rural Population | 3 | 2015 | 270 | 0.130 |
Why?
|
| Neglected Diseases | 1 | 2020 | 152 | 0.130 |
Why?
|
| Fertilization | 1 | 2017 | 44 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 271 | 0.130 |
Why?
|
| Phylogeny | 1 | 2019 | 684 | 0.130 |
Why?
|
| Focus Groups | 4 | 2021 | 239 | 0.130 |
Why?
|
| Pregnancy in Adolescence | 2 | 2015 | 54 | 0.130 |
Why?
|
| Epidemiologic Methods | 3 | 1995 | 91 | 0.130 |
Why?
|
| Intrauterine Devices | 2 | 1995 | 13 | 0.120 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 422 | 0.120 |
Why?
|
| Evaluation Studies as Topic | 2 | 2015 | 226 | 0.120 |
Why?
|
| England | 2 | 2012 | 59 | 0.120 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2017 | 50 | 0.120 |
Why?
|
| Epidemiologic Research Design | 1 | 2016 | 6 | 0.120 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 2289 | 0.120 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 502 | 0.120 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 2891 | 0.120 |
Why?
|
| Congenital Abnormalities | 3 | 2016 | 325 | 0.120 |
Why?
|
| Intensive Care, Neonatal | 1 | 2016 | 55 | 0.120 |
Why?
|
| Pregnancy, Twin | 2 | 2014 | 191 | 0.120 |
Why?
|
| Research Report | 1 | 2016 | 73 | 0.120 |
Why?
|
| Feasibility Studies | 5 | 2017 | 820 | 0.120 |
Why?
|
| Perineum | 2 | 1987 | 40 | 0.120 |
Why?
|
| Cetylpyridinium | 1 | 2015 | 1 | 0.120 |
Why?
|
| Fear | 1 | 2017 | 190 | 0.120 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 700 | 0.120 |
Why?
|
| Mouthwashes | 1 | 2015 | 10 | 0.120 |
Why?
|
| Checklist | 1 | 2016 | 98 | 0.120 |
Why?
|
| Attitude to Health | 2 | 2009 | 246 | 0.120 |
Why?
|
| Oral Health | 1 | 2015 | 28 | 0.120 |
Why?
|
| Guatemala | 5 | 2014 | 63 | 0.120 |
Why?
|
| Data Collection | 4 | 2021 | 370 | 0.120 |
Why?
|
| Communication | 2 | 2017 | 540 | 0.120 |
Why?
|
| Pakistan | 5 | 2014 | 99 | 0.110 |
Why?
|
| Menstruation | 2 | 2007 | 28 | 0.110 |
Why?
|
| Patient Preference | 1 | 2017 | 150 | 0.110 |
Why?
|
| Tetanus Toxoid | 2 | 1995 | 47 | 0.110 |
Why?
|
| Nonlinear Dynamics | 1 | 1995 | 54 | 0.110 |
Why?
|
| Body Weights and Measures | 1 | 2015 | 33 | 0.110 |
Why?
|
| Qualitative Research | 5 | 2021 | 709 | 0.110 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2015 | 68 | 0.110 |
Why?
|
| Clinical Coding | 1 | 2015 | 14 | 0.110 |
Why?
|
| India | 5 | 2014 | 231 | 0.110 |
Why?
|
| Africa, Northern | 4 | 2004 | 10 | 0.110 |
Why?
|
| Health Education | 1 | 2016 | 226 | 0.110 |
Why?
|
| Intention | 1 | 2015 | 102 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2021 | 703 | 0.110 |
Why?
|
| Leadership | 1 | 2017 | 246 | 0.110 |
Why?
|
| Cotinine | 1 | 2014 | 25 | 0.110 |
Why?
|
| Tetanus | 1 | 1995 | 22 | 0.110 |
Why?
|
| Child, Preschool | 6 | 2019 | 15002 | 0.110 |
Why?
|
| Wounds and Injuries | 2 | 2011 | 395 | 0.110 |
Why?
|
| Tobacco Use Disorder | 1 | 2015 | 87 | 0.110 |
Why?
|
| Southeastern United States | 1 | 2014 | 35 | 0.110 |
Why?
|
| France | 6 | 2006 | 90 | 0.110 |
Why?
|
| Health Behavior | 2 | 2009 | 386 | 0.100 |
Why?
|
| Cervix Uteri | 1 | 1994 | 57 | 0.100 |
Why?
|
| Analgesia, Obstetrical | 1 | 1994 | 9 | 0.100 |
Why?
|
| Education, Public Health Professional | 1 | 2014 | 6 | 0.100 |
Why?
|
| Dental Prophylaxis | 1 | 2013 | 3 | 0.100 |
Why?
|
| Tropical Climate | 1 | 2014 | 51 | 0.100 |
Why?
|
| Health Surveys | 3 | 2010 | 258 | 0.100 |
Why?
|
| Breast Feeding | 1 | 2015 | 234 | 0.100 |
Why?
|
| Tobacco Use Cessation | 1 | 2013 | 5 | 0.100 |
Why?
|
| Infertility, Male | 1 | 2017 | 296 | 0.100 |
Why?
|
| Kenya | 4 | 2014 | 60 | 0.100 |
Why?
|
| Sleep | 1 | 2017 | 374 | 0.100 |
Why?
|
| Infant Care | 2 | 2010 | 45 | 0.100 |
Why?
|
| Immunization | 1 | 1995 | 269 | 0.100 |
Why?
|
| Thinness | 1 | 2013 | 71 | 0.100 |
Why?
|
| Life Change Events | 2 | 2004 | 59 | 0.100 |
Why?
|
| Epidemics | 1 | 2013 | 57 | 0.100 |
Why?
|
| Sex Education | 1 | 1993 | 18 | 0.100 |
Why?
|
| Hospitals, Public | 3 | 2010 | 48 | 0.100 |
Why?
|
| Professional Competence | 1 | 2014 | 97 | 0.100 |
Why?
|
| Rubella | 2 | 1983 | 17 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2016 | 327 | 0.100 |
Why?
|
| Altitude | 1 | 2013 | 22 | 0.100 |
Why?
|
| Gingival Hemorrhage | 1 | 2012 | 2 | 0.090 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 371 | 0.090 |
Why?
|
| Gingival Recession | 1 | 2012 | 2 | 0.090 |
Why?
|
| AIDS Serodiagnosis | 1 | 2013 | 52 | 0.090 |
Why?
|
| Time Factors | 7 | 2016 | 6165 | 0.090 |
Why?
|
| Prejudice | 2 | 2003 | 39 | 0.090 |
Why?
|
| Family Planning Services | 2 | 1989 | 40 | 0.090 |
Why?
|
| Health Communication | 1 | 2012 | 30 | 0.090 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 198 | 0.090 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 829 | 0.090 |
Why?
|
| Puerto Rico | 3 | 2016 | 54 | 0.090 |
Why?
|
| Asia | 3 | 2016 | 123 | 0.090 |
Why?
|
| Antiprotozoal Agents | 1 | 2012 | 41 | 0.090 |
Why?
|
| Pregnancy Complications, Hematologic | 2 | 2003 | 29 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2014 | 462 | 0.090 |
Why?
|
| Insulin-Secreting Cells | 1 | 2012 | 133 | 0.090 |
Why?
|
| Referral and Consultation | 3 | 2006 | 551 | 0.090 |
Why?
|
| Fasting | 1 | 2012 | 304 | 0.090 |
Why?
|
| Health Services Research | 3 | 2008 | 178 | 0.080 |
Why?
|
| History, 15th Century | 1 | 2011 | 12 | 0.080 |
Why?
|
| Dexamethasone | 1 | 2012 | 249 | 0.080 |
Why?
|
| Developed Countries | 1 | 2011 | 43 | 0.080 |
Why?
|
| Uterus | 1 | 2015 | 540 | 0.080 |
Why?
|
| Community Networks | 1 | 2010 | 30 | 0.080 |
Why?
|
| Healthcare Disparities | 2 | 2021 | 513 | 0.080 |
Why?
|
| Drug Utilization | 3 | 2016 | 163 | 0.080 |
Why?
|
| Fetal Death | 2 | 2010 | 115 | 0.080 |
Why?
|
| Inservice Training | 1 | 2010 | 56 | 0.080 |
Why?
|
| Cause of Death | 6 | 2010 | 501 | 0.080 |
Why?
|
| Mother-Child Relations | 2 | 2010 | 83 | 0.080 |
Why?
|
| Medical Staff, Hospital | 1 | 2010 | 90 | 0.080 |
Why?
|
| Finland | 6 | 2006 | 46 | 0.080 |
Why?
|
| Nursing Methodology Research | 1 | 2009 | 13 | 0.080 |
Why?
|
| Insurance, Dental | 1 | 2009 | 1 | 0.080 |
Why?
|
| Ultrasonography | 3 | 1991 | 942 | 0.080 |
Why?
|
| Dental Care | 1 | 2009 | 8 | 0.080 |
Why?
|
| Oral Hygiene | 1 | 2009 | 9 | 0.080 |
Why?
|
| Health Planning | 1 | 1989 | 16 | 0.080 |
Why?
|
| Rural Health | 2 | 2016 | 45 | 0.080 |
Why?
|
| Sexual Partners | 1 | 2010 | 79 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2010 | 270 | 0.080 |
Why?
|
| Perinatology | 1 | 1990 | 32 | 0.080 |
Why?
|
| Body Weight | 1 | 2013 | 985 | 0.080 |
Why?
|
| Neoplasms | 3 | 2016 | 2977 | 0.080 |
Why?
|
| Primary Prevention | 1 | 2011 | 182 | 0.070 |
Why?
|
| Interviews as Topic | 3 | 2016 | 455 | 0.070 |
Why?
|
| Drug Prescriptions | 2 | 1991 | 230 | 0.070 |
Why?
|
| Preventive Health Services | 2 | 2006 | 58 | 0.070 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2010 | 169 | 0.070 |
Why?
|
| Umbilical Cord | 1 | 2009 | 54 | 0.070 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 782 | 0.070 |
Why?
|
| Genotype | 1 | 2015 | 2588 | 0.070 |
Why?
|
| Emergency Medical Services | 1 | 2013 | 352 | 0.070 |
Why?
|
| Curriculum | 2 | 2011 | 792 | 0.070 |
Why?
|
| Cultural Characteristics | 2 | 2004 | 45 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 563 | 0.070 |
Why?
|
| Animals | 7 | 2025 | 33660 | 0.070 |
Why?
|
| Epidemiologic Studies | 2 | 2016 | 39 | 0.070 |
Why?
|
| Community Health Workers | 1 | 1989 | 87 | 0.070 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2008 | 52 | 0.070 |
Why?
|
| Sampling Studies | 2 | 2003 | 76 | 0.070 |
Why?
|
| Blood Chemical Analysis | 1 | 1988 | 80 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2012 | 1112 | 0.070 |
Why?
|
| Resuscitation | 1 | 2010 | 258 | 0.070 |
Why?
|
| Anemia | 2 | 2003 | 352 | 0.070 |
Why?
|
| Health Care Surveys | 2 | 2013 | 276 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2012 | 686 | 0.070 |
Why?
|
| Insulin | 1 | 2012 | 1146 | 0.070 |
Why?
|
| Hospital Departments | 1 | 1987 | 15 | 0.070 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 129 | 0.060 |
Why?
|
| Alcohol Drinking | 1 | 2009 | 339 | 0.060 |
Why?
|
| Aid to Families with Dependent Children | 1 | 2006 | 1 | 0.060 |
Why?
|
| Urban Population | 3 | 2015 | 281 | 0.060 |
Why?
|
| Maternal-Child Health Centers | 1 | 2006 | 5 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2006 | 928 | 0.060 |
Why?
|
| French Guiana | 2 | 2018 | 2 | 0.060 |
Why?
|
| North America | 1 | 2007 | 256 | 0.060 |
Why?
|
| China | 4 | 2015 | 276 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2011 | 1241 | 0.060 |
Why?
|
| Food Services | 1 | 2006 | 40 | 0.060 |
Why?
|
| Hemagglutination Tests | 1 | 2026 | 10 | 0.060 |
Why?
|
| Meperidine | 1 | 2006 | 5 | 0.060 |
Why?
|
| Labor Pain | 1 | 2006 | 3 | 0.060 |
Why?
|
| Massachusetts | 3 | 2016 | 116 | 0.060 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2007 | 80 | 0.060 |
Why?
|
| Private Practice | 1 | 1986 | 21 | 0.060 |
Why?
|
| Pregnancy, High-Risk | 3 | 2006 | 39 | 0.060 |
Why?
|
| Risk | 4 | 2013 | 723 | 0.060 |
Why?
|
| Age Distribution | 2 | 2006 | 421 | 0.060 |
Why?
|
| Acid-Base Equilibrium | 1 | 2006 | 60 | 0.060 |
Why?
|
| Hospitals, Maternity | 3 | 2011 | 8 | 0.060 |
Why?
|
| Information Dissemination | 1 | 2008 | 194 | 0.060 |
Why?
|
| Texas | 1 | 2014 | 3655 | 0.060 |
Why?
|
| Vagina | 2 | 1990 | 207 | 0.060 |
Why?
|
| Elective Surgical Procedures | 1 | 2006 | 161 | 0.060 |
Why?
|
| Neonatal Screening | 1 | 2007 | 204 | 0.060 |
Why?
|
| Homicide | 1 | 2005 | 34 | 0.060 |
Why?
|
| Dengue Virus | 2 | 2018 | 135 | 0.060 |
Why?
|
| ROC Curve | 2 | 2018 | 609 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2006 | 197 | 0.050 |
Why?
|
| Research | 2 | 2001 | 264 | 0.050 |
Why?
|
| Acidosis | 1 | 2006 | 97 | 0.050 |
Why?
|
| Anthropometry | 2 | 2016 | 187 | 0.050 |
Why?
|
| Vaccines, Attenuated | 1 | 2025 | 174 | 0.050 |
Why?
|
| Problem Solving | 1 | 2004 | 61 | 0.050 |
Why?
|
| Papio | 1 | 1983 | 57 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 2 | 2020 | 549 | 0.050 |
Why?
|
| Retroviridae | 1 | 1983 | 182 | 0.050 |
Why?
|
| Receptors, Virus | 1 | 1983 | 95 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 2574 | 0.050 |
Why?
|
| Health Facilities | 2 | 2016 | 66 | 0.050 |
Why?
|
| Netherlands | 2 | 1997 | 51 | 0.050 |
Why?
|
| Cardiovascular Diseases | 3 | 2011 | 2107 | 0.050 |
Why?
|
| Urban Health | 1 | 2003 | 83 | 0.050 |
Why?
|
| Organ Size | 1 | 2003 | 408 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2006 | 462 | 0.050 |
Why?
|
| Suicide | 1 | 2005 | 205 | 0.050 |
Why?
|
| Postnatal Care | 2 | 2012 | 51 | 0.050 |
Why?
|
| California | 1 | 2022 | 127 | 0.050 |
Why?
|
| Aged | 1 | 2020 | 20822 | 0.040 |
Why?
|
| Environment | 1 | 2002 | 149 | 0.040 |
Why?
|
| Statistics as Topic | 4 | 1995 | 241 | 0.040 |
Why?
|
| Models, Biological | 1 | 2006 | 1375 | 0.040 |
Why?
|
| Reference Values | 1 | 2002 | 674 | 0.040 |
Why?
|
| Epigenomics | 1 | 2022 | 181 | 0.040 |
Why?
|
| Pharmacovigilance | 1 | 2021 | 12 | 0.040 |
Why?
|
| Age Factors | 4 | 2015 | 2822 | 0.040 |
Why?
|
| Health Status Indicators | 2 | 2007 | 111 | 0.040 |
Why?
|
| Antigens, Viral | 2 | 2018 | 394 | 0.040 |
Why?
|
| Saliva | 2 | 2014 | 124 | 0.040 |
Why?
|
| Pregnancy, Ectopic | 2 | 2004 | 21 | 0.040 |
Why?
|
| Canada | 1 | 2001 | 325 | 0.040 |
Why?
|
| Clinical Protocols | 2 | 2012 | 229 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2006 | 484 | 0.040 |
Why?
|
| Causality | 2 | 2004 | 89 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2001 | 232 | 0.040 |
Why?
|
| Forecasting | 2 | 2020 | 349 | 0.040 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2020 | 46 | 0.040 |
Why?
|
| Labor Stage, Second | 2 | 2010 | 15 | 0.040 |
Why?
|
| Minority Groups | 1 | 2022 | 259 | 0.040 |
Why?
|
| Birthing Centers | 1 | 2019 | 9 | 0.040 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 1 | 2019 | 14 | 0.040 |
Why?
|
| Life Style | 1 | 2003 | 450 | 0.040 |
Why?
|
| Health Plan Implementation | 1 | 2019 | 39 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2021 | 190 | 0.040 |
Why?
|
| Genotyping Techniques | 1 | 2019 | 110 | 0.040 |
Why?
|
| Penicillin G Benzathine | 1 | 2019 | 20 | 0.040 |
Why?
|
| Asia, Southeastern | 1 | 2018 | 22 | 0.040 |
Why?
|
| Labor Stage, First | 2 | 2010 | 8 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2001 | 358 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 1205 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 233 | 0.030 |
Why?
|
| Haplotypes | 1 | 2019 | 517 | 0.030 |
Why?
|
| Cross Reactions | 1 | 2018 | 158 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 359 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2006 | 1212 | 0.030 |
Why?
|
| Switzerland | 1 | 1997 | 16 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 756 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2013 | 1439 | 0.030 |
Why?
|
| Patient Selection | 1 | 2001 | 723 | 0.030 |
Why?
|
| Exons | 1 | 2019 | 759 | 0.030 |
Why?
|
| Physician's Role | 1 | 1998 | 164 | 0.030 |
Why?
|
| Government Agencies | 1 | 2016 | 12 | 0.030 |
Why?
|
| Needs Assessment | 2 | 2011 | 173 | 0.030 |
Why?
|
| Community Health Centers | 1 | 2016 | 35 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 1453 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 409 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2022 | 1075 | 0.030 |
Why?
|
| House Calls | 1 | 2015 | 35 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2017 | 231 | 0.030 |
Why?
|
| Publishing | 1 | 2016 | 105 | 0.030 |
Why?
|
| Smoking Prevention | 1 | 2015 | 34 | 0.030 |
Why?
|
| Puerperal Disorders | 1 | 2015 | 47 | 0.030 |
Why?
|
| Behavior Therapy | 1 | 2017 | 271 | 0.030 |
Why?
|
| Hospitals, District | 2 | 2006 | 6 | 0.030 |
Why?
|
| Students | 1 | 2017 | 247 | 0.030 |
Why?
|
| Colposcopy | 1 | 1994 | 17 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 236 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 1995 | 225 | 0.030 |
Why?
|
| Obstetrical Forceps | 1 | 1994 | 8 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2015 | 209 | 0.030 |
Why?
|
| Consensus | 1 | 2016 | 521 | 0.030 |
Why?
|
| Anesthesia, Epidural | 1 | 1994 | 19 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 1707 | 0.030 |
Why?
|
| Models, Educational | 1 | 2014 | 78 | 0.020 |
Why?
|
| Abortion, Induced | 2 | 2004 | 89 | 0.020 |
Why?
|
| Blood Banks | 1 | 2013 | 11 | 0.020 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2013 | 10 | 0.020 |
Why?
|
| Nurse Midwives | 1 | 2013 | 9 | 0.020 |
Why?
|
| Contraindications | 1 | 1993 | 75 | 0.020 |
Why?
|
| Cell Phone | 1 | 2013 | 33 | 0.020 |
Why?
|
| Transients and Migrants | 1 | 1993 | 30 | 0.020 |
Why?
|
| Fetal Mortality | 1 | 2012 | 7 | 0.020 |
Why?
|
| Delphi Technique | 1 | 2014 | 277 | 0.020 |
Why?
|
| United Kingdom | 1 | 1993 | 264 | 0.020 |
Why?
|
| Feedback | 1 | 1993 | 143 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1481 | 0.020 |
Why?
|
| Attitude | 1 | 2012 | 109 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 1993 | 149 | 0.020 |
Why?
|
| Scotland | 1 | 1991 | 24 | 0.020 |
Why?
|
| Periodontics | 1 | 2011 | 2 | 0.020 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2004 | 110 | 0.020 |
Why?
|
| Injections | 1 | 2011 | 109 | 0.020 |
Why?
|
| Civil Defense | 1 | 2010 | 8 | 0.020 |
Why?
|
| Information Systems | 2 | 1989 | 28 | 0.020 |
Why?
|
| Antigens, Protozoan | 1 | 2010 | 77 | 0.020 |
Why?
|
| Uterine Hemorrhage | 1 | 2010 | 41 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 1990 | 48 | 0.020 |
Why?
|
| Magnesium Sulfate | 1 | 2010 | 52 | 0.020 |
Why?
|
| Hematologic Tests | 1 | 1990 | 36 | 0.020 |
Why?
|
| Birth Injuries | 1 | 1990 | 20 | 0.020 |
Why?
|
| Emergencies | 1 | 2010 | 170 | 0.020 |
Why?
|
| Internet | 1 | 2013 | 419 | 0.020 |
Why?
|
| Traction | 1 | 2009 | 10 | 0.020 |
Why?
|
| Placenta, Retained | 1 | 2009 | 12 | 0.020 |
Why?
|
| Oxygen | 1 | 2013 | 549 | 0.020 |
Why?
|
| Fetal Macrosomia | 1 | 2009 | 20 | 0.020 |
Why?
|
| Medically Underserved Area | 1 | 1990 | 87 | 0.020 |
Why?
|
| Sex Factors | 2 | 1990 | 1343 | 0.020 |
Why?
|
| Contraception | 1 | 1989 | 61 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2010 | 117 | 0.020 |
Why?
|
| Temperament | 1 | 2009 | 31 | 0.020 |
Why?
|
| Teaching | 1 | 2010 | 196 | 0.020 |
Why?
|
| Psychology, Child | 1 | 2009 | 48 | 0.020 |
Why?
|
| Telemedicine | 1 | 2015 | 525 | 0.020 |
Why?
|
| Bolivia | 1 | 2008 | 12 | 0.020 |
Why?
|
| Sutures | 1 | 2009 | 62 | 0.020 |
Why?
|
| Health Services Misuse | 1 | 1988 | 23 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 1014 | 0.020 |
Why?
|
| Resilience, Psychological | 1 | 2010 | 79 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 1990 | 185 | 0.020 |
Why?
|
| Japan | 1 | 1989 | 160 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1988 | 162 | 0.020 |
Why?
|
| Decision Trees | 1 | 1988 | 57 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2010 | 226 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2010 | 362 | 0.020 |
Why?
|
| Defensive Medicine | 1 | 2007 | 8 | 0.020 |
Why?
|
| Dermatitis, Contact | 1 | 1987 | 6 | 0.020 |
Why?
|
| Nicotine | 1 | 2008 | 115 | 0.020 |
Why?
|
| Hypersensitivity, Immediate | 1 | 1987 | 31 | 0.020 |
Why?
|
| Medical Records | 1 | 2007 | 174 | 0.020 |
Why?
|
| Benin | 1 | 2006 | 2 | 0.010 |
Why?
|
| Women, Working | 1 | 1986 | 8 | 0.010 |
Why?
|
| Physicians | 1 | 2013 | 626 | 0.010 |
Why?
|
| Women | 1 | 1986 | 17 | 0.010 |
Why?
|
| State Government | 1 | 2006 | 30 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 2006 | 109 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 2107 | 0.010 |
Why?
|
| Medical Audit | 1 | 2006 | 97 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2006 | 409 | 0.010 |
Why?
|
| Death Certificates | 1 | 2004 | 10 | 0.010 |
Why?
|
| Medical Record Linkage | 1 | 2004 | 10 | 0.010 |
Why?
|
| International Classification of Diseases | 1 | 2005 | 91 | 0.010 |
Why?
|
| Nutrition Surveys | 1 | 2006 | 331 | 0.010 |
Why?
|
| Aftercare | 1 | 2006 | 156 | 0.010 |
Why?
|
| Seizures | 1 | 1990 | 874 | 0.010 |
Why?
|
| Menarche | 1 | 1984 | 31 | 0.010 |
Why?
|
| Adsorption | 1 | 1983 | 33 | 0.010 |
Why?
|
| Chiroptera | 1 | 1983 | 15 | 0.010 |
Why?
|
| Haplorhini | 1 | 1983 | 106 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2006 | 292 | 0.010 |
Why?
|
| Virus Cultivation | 1 | 1983 | 70 | 0.010 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2004 | 60 | 0.010 |
Why?
|
| Hospitals, Rural | 1 | 2003 | 16 | 0.010 |
Why?
|
| Rubella Vaccine | 1 | 1983 | 2 | 0.010 |
Why?
|
| Body Height | 1 | 1984 | 192 | 0.010 |
Why?
|
| Health Priorities | 1 | 2003 | 42 | 0.010 |
Why?
|
| Health Care Reform | 1 | 2003 | 50 | 0.010 |
Why?
|
| Dogs | 1 | 1983 | 615 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2006 | 342 | 0.010 |
Why?
|
| Eclampsia | 1 | 2000 | 27 | 0.010 |
Why?
|
| Insurance, Health | 1 | 2001 | 142 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2000 | 115 | 0.010 |
Why?
|
| Pregnancy Trimesters | 1 | 2000 | 34 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1983 | 977 | 0.010 |
Why?
|
| Rats | 1 | 1983 | 3372 | 0.010 |
Why?
|
| Greece | 1 | 1995 | 12 | 0.010 |
Why?
|
| MEDLINE | 1 | 1995 | 18 | 0.010 |
Why?
|
| Sweden | 1 | 1995 | 39 | 0.010 |
Why?
|
| Indonesia | 1 | 1995 | 21 | 0.010 |
Why?
|
| Italy | 1 | 1995 | 109 | 0.010 |
Why?
|
| Norway | 1 | 1995 | 31 | 0.010 |
Why?
|
| Mice | 1 | 1983 | 18160 | 0.000 |
Why?
|
| Cost Control | 1 | 1986 | 22 | 0.000 |
Why?
|
| Allergens | 1 | 1987 | 344 | 0.000 |
Why?
|
| Object Attachment | 1 | 1985 | 64 | 0.000 |
Why?
|